Following the accomplishment of the PEGS Summit, 2022 BIO International Convention, and 13th Annual World ADC, this month’s Creative Biolabs event was held this week at the DoubleTree Boston North Shore Convention Center. The 13th World Bispecific Summit also concluded successfully on September 22nd.
With more clinical candidates and commercial success than ever within this rapidly developing space, multi-specifics are evidently the fourth wave of drug discovery. With this, there has never been a hotter time to double down and deliver the holy grail of precision oncology as the true power of bispecifics is recognized.
The 13th Annual World Bispecific Summit delivered a greater scope and penetration of innovative technical content. This year’s exhibition covered unique target discovery, mechanistic diversity and translational science, as well as novel formats, product design and manufacturability challenges faced in the bispecific field.
“We are glad to gather around with our old friends and learn how we can give a hand to their ongoing project,” said a delegate of Creative Biolabs, “as well as meet new faces that might need partners to advance their new drug discovery jointly. We’ve prepared fancy gifts as a way of saying thank you to those who stop by our booth.”
Creative Biolabs is proud to exhibit and participate in industry conferences where our scientists showcase innovative drug discovery solutions. Whether you are diving into scientific research, biopharmaceutical discovery and development, or industrial manufacturing, we strongly encourage you to come and meet us at our upcoming conferences!
Stay up-to-date on our forthcoming exhibitions:
- The 10th Annual Immuno-Oncology Summit
- The Antibody Engineering & Therapeutics (US) 2022
Visit the Event Page to track our next in-person event and book a meeting in advance!